Hyperserotonemia in Egyptian autistic children: Relation to allergic manifestations

Journal of Pediatric Neurology

Volumn 6, Issue 3, 2008, Pages 227-236

  Mostafa, Gehan A ^a,b   EL Sherif, Dalia F ^a   Hamza, Rasha T ^a   AL Shehab, Abeer ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Allergy; Autism; Hyperserotonemia; Immune; Serotonin

Indexed keywords

BRONCHODILATING AGENT; IMMUNOGLOBULIN E; SEROTONIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASIAN; ASTHMA; ATOPIC DERMATITIS; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; EGYPT; FEMALE; HUMAN; HYPERSEROTONEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; MALE; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SEROTONIN BLOOD LEVEL;

EID: 49649096599     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: 10.1055/s-0035-1557466     Document Type: Article

References (49)

1. R. Dalton, M.A. Forman and N.W. Boris, Pervasive developmental disorders and childhood psychosis, in: Nelson Textbook of Pediatrics, (17th ed.), R.E. Behrman, R.M. Kliegman and H.B. Jenson, eds, Philadelphia: WB Saunders, 2004, pp. 93-94.
2. M. Xue, M. Brimacombe, J. Chaaban, B. Zimmerman-Bier and G.C. Wagner, Autism spectrum disorders: Concurrent clinical disorders, J Child Neurol 23 (2008), 6-13.
3. P.M. Kidd, Autism, an extreme challenge to integrative medicine, Part 1: The knowledge base, Altern Med Rev 7 (2002), 292-316.
4. H.H. Cohly and A. Panja, Immunological findings in autism, Int Rev Neurobiol 71 (2005), 317-341.
5. N. Narita, M. Kato, M. Tazoe, K. Miyazaki, M. Narita and N. Okado, Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid- exposure rat: Putative animal models for autism. Pediatr Res 52 (2002). 576-579.
6. P.M. Whitaker-Azmitia, Serotonin and brain development: Role in human developmental diseases, Brain Res Bul 56 (2001), 479-485.
7. G.R. Delong, L.A. Teague and M. McSwain Kamran, Effects of fluoxetine treatment in young children with idiopathic autism, Dev Med Child Neurol 40 (1998), 551-562.
8. T.E. Moffitt, G.L. Brammer, A. Caspi et al., Whole blood serotonin relates to violence in an epidemiological study, Biol Psychiatry 43 (1998), 446-457.
9. H.H. Cohly and A. Panja, Immunological findings in autism, Int Rev Neurobiol 71 (2005), 317-341.
10. B. Jepson, Understanding Autism. The Physiologic Basis and Biomedical Intervention Options of Autism Spectrum Disorders. Children's Biomedical Center of Utah, USA: Sandy, 2003.
11. M.J. Dochniak, Autism spectrum disorders-exogenous protein insult. Med Hypotheses 89 (2007). 545-549.
12. S. Lucarelli. T. Frediani. A.M. Zingoni et al., Food allergy and infantile autism, Panminerva Med 37 (1995), 137-141.
13. G. Ménard, V. Turmel and E.Y. Bissonnette, Serotonin modulates the cytokine network in the lung: Involvement of prostaglandin E2, Clin Exp Immunol 150 (2007), 340-348.
14. I. Cazzola and M.G. Matera, 5-HT modifiers as a potential treatment of asthma, Trends Pharmacol Sci 21 (2000), 13-16.
15. N.K. Burgess, T.L. Sweeten and W.M. McMahon, Fujinami RS. Hyperserotoninemia and altered immunity in autism, J Autism Dev Disord 36 (2006), 697-704.
16. L. Klareskog, U. Forsum, A. Scheynius, D. Kabelitz and H. Wigzell, Evidence in support of a self-perpetuating HLA-DR dependent delayed-type cell reaction in rheumatoid arthritis, Proceed Nat Acad Sci USA 79 (1982), 3632-3636.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (4th ed.). Washington DC: American Psychiatric Association, 1994.
18. E. Schopler, R.J. Reichler and B.R. Renner, The Childhood Autism Rating Scale (CARS), for Diagnostic Screening and Classification in Autism, New York: Irvington, 1986.
19. National Heart, Lung and Blood Institute (NHLBI). Global Initiative for Asthma Program: Pocket Guide for Asthma Management and prevention in children (updated from the NHLBI/WHO Workshop Report: Global strategy for asthma Management and prevention issued January 1995 and revised 2002). NIH Publication No 02-3659. U.S. Department of Health and Human Services, National institutes of Health, 2003. Publications are available from http://www.ginasthma.com.
20. J.M. Hanifin and G. Rajka, Diagnostic features of atopic dermatitis, Acta Derm Venereol (Suppl) Stockh 92 (1980), 44-47.
21. B. Kunz, A.P. Oranje, L. Labreze, J.F. Staider, J. Ring and A. Taleb, Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis, Dermatology 195 (1997), 10-19.
22. J. Bousquet, P. Van Cauwenberge and N. Khaltaev, ARIA Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol 108(5 Suppl) (2001), S147-S334.
23. A.H. Liu, R.A. Covar, J.D. Spahn and D.Y.M. Leung, Childhood asthma, in: Nelson Textbook of Pediatrics, (18th ed.), R.M. Kliegman, R.E. Behrman, H.B. Jenson and B.E Stanton, eds, Philadelphia: WB Saunders, 2008, pp. 953-969.
24. L.M. Terman and M.A. Merrill, Stanford-Binet Intelligence Scale: Manual for the 3rd Revision Form L-M. Chicago: The Riverside Publishing Company, 1973.
25. S.M. Geaghan, Normal blood values: Selected reference values for neonatal, pediatric and adult populations, in: Hematology: Basic Principles and Practice, (3rd ed.), R. Hoffman, E.J. Benz and S.J. Shattil, eds, New York: Churchill Livingstone, 2000, pp. 2520-2528.
26. G.R. Delong, Autism: New data suggested a new hypothesis, Neurology 52 (1999), 911-916.
27. G.M. Anderson, D.X. Freedman, D.J. Cohen et al., Whole blood serotonin in autistic and normal subjects, J Child Psychol Psychiatry 28 (1987), 885-900.
28. E.J. Mulder, G.M. Anderson, I.P. Kema et al., Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution and behavioral correlates, J Am Acad Child Adoles Psychiatry 43 (2004), 491-499.
29. E.H. Cook, Autism: Review of neurochemical investigation, Synapse 6 (1990), 292-308.
30. F.H. Cook. R.C. Arora. G.M. Anderson et al., Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder, Life Sci 52 (1993), 2005-2015.
31. M. Leboyer, A. Philippe, M.P. Bouvard et al., Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 45 (1999). 158-163.
32. E.H. Cook, D.A. Charak and J. Arida, Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder, Psychiatry Res 52 (1994), 25-33.
33. N. Yirmiya, T. Pilowsky, L. Nemanov et al., Evidence for an association with the serotonin transporter promotor region polymorphism and autism, Am J Med Genet 105 (2001). 381-386.
34. E.H. Cook and B.L. Leventhal, The serotonin system in autism, Curr Opinn Pediatr 8 (1996), 348-354.
35. M. Narayan, S. Srinath, G.M. Anderson and D.B. Meundi, Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindole acetic acid in autism, Biol Psychiatr 33 (1993), 630-635.
36. D.C. Chugani, O. Muzik, R. Rothermel et al., Altered serotonin synthesis in the dentatothalamcortical pathway in autistic boys, Ann Neurol 42 (1997), 666-669.
37. R.D. Todd and R.D. Ciaranello, Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child, Proc Natl Acad Sci USA 82 (1985), 612-616.
38. G.A. Mostafa, R.T. Hamza and H.H. El-Shahawi, Allergic manifestations in autistic children: Relation to disease severity, J Pediatr Neurol 6 (2008), 115-123.
39. M. Akidis, Healthy immune response to allergens: T regulatory cells and more, Curr Opin Immunol 18 (2006), 738-744.
40. C. Millward, M. Ferriter, S. Calver and G. Connell-Jones, Gluten- and casein free diets for autistic spectrum disorder, Cochrane Database Syst Rev 2 (2004), CD003498.
41. C.C. Mok and C.S. Lau, Pathogenesis of systemic lupus erythematosus, J Clin Pathol 56 (2003), 481-490.
42. G.P. Geba, W. Ptak, G.M. Anderson et al., Delayed-type hypersensitivity in mast cell-deficient mice: Dependence on platelets for expression of contact sensitivity, J Immunol 157 (1996), 557-565.
43. P.W. Askenase, W.R. Herzog, I. Millet et al., Serotonin initiation of delayed-type hypersensitivity: Mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody, Skin Pharmacol 4(Suppl 1) (1991), 25-42.
44. R.P. Warren and V.K. Singh, Elevated serotonin levels in autism: Association with the major histocompatibility complex, Neuropsychobiology 34 (1996), 72-75.
45. A.R. Torres, A. Maciulis and D. Odell, The association of MHC genes with autism, Front Biosci 6 (2001), 936-943.
46. D. Odell, A. Maciulis, A. Cutler et al., Confirmation of the association of C4B null allele in autism, Human Immunol 66 (2005), 140-145.
47. K.E Lesch, D. Bengel, A. Heils et al., Association of anxiety-related traits with a polymorphismin the serotonin transporter gene regulatory region, Science 274 (1996), 1527-1231.
48. C.H. Huang and S.L. Santangelo, Autism and serotonin transporter gene polymorphisms: A systematic review and meta-analysis, Am J Med Genet B Neuropsychiatr Genet (2008), (in press).
49. D.C. Chugani, Q. Muzik, M. Behen et al., Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Ann Neurol 45 (1999), 287-295.